雌激素受体α在衰老和慢性疾病中的作用。

José V V Isola, Sunghwan Ko, Sarah R Ocañas, Michael B Stout
{"title":"雌激素受体α在衰老和慢性疾病中的作用。","authors":"José V V Isola,&nbsp;Sunghwan Ko,&nbsp;Sarah R Ocañas,&nbsp;Michael B Stout","doi":"10.20900/agmr20230005","DOIUrl":null,"url":null,"abstract":"<p><p>Estrogen receptor alpha (ERα) plays a crucial role in reproductive function in both sexes. It also mediates cellular responses to estrogens in multiple nonreproductive organ systems, many of which regulate systemic metabolic homeostasis and inflammatory processes in mammals. The loss of estrogens and/or ERα agonism during aging is associated with the emergence of several comorbid conditions, particularly in females undergoing the menopausal transition. Emerging data also suggests that male mammals likely benefit from ERα agonism if done in a way that circumvents feminizing characteristics. This has led us, and others, to speculate that tissue-specific ERα agonism may hold therapeutic potential for curtailing aging and chronic disease burden in males and females that are at high-risk of cancer and/or cardiovascular events with traditional estrogen replacement therapies. In this mini-review, we emphasize the role of ERα in the brain and liver, summarizing recent evidence that indicates these two organs systems mediate the beneficial effects of estrogens on metabolism and inflammation during aging. We also discuss how 17α-estradiol administration elicits health benefits in an ERα-dependent manner, which provides proof-of-concept that ERα may be a druggable target for attenuating aging and age-related disease burden.</p>","PeriodicalId":72094,"journal":{"name":"Advances in geriatric medicine and research","volume":"5 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327608/pdf/","citationCount":"0","resultStr":"{\"title\":\"Role of Estrogen Receptor α in Aging and Chronic Disease.\",\"authors\":\"José V V Isola,&nbsp;Sunghwan Ko,&nbsp;Sarah R Ocañas,&nbsp;Michael B Stout\",\"doi\":\"10.20900/agmr20230005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Estrogen receptor alpha (ERα) plays a crucial role in reproductive function in both sexes. It also mediates cellular responses to estrogens in multiple nonreproductive organ systems, many of which regulate systemic metabolic homeostasis and inflammatory processes in mammals. The loss of estrogens and/or ERα agonism during aging is associated with the emergence of several comorbid conditions, particularly in females undergoing the menopausal transition. Emerging data also suggests that male mammals likely benefit from ERα agonism if done in a way that circumvents feminizing characteristics. This has led us, and others, to speculate that tissue-specific ERα agonism may hold therapeutic potential for curtailing aging and chronic disease burden in males and females that are at high-risk of cancer and/or cardiovascular events with traditional estrogen replacement therapies. In this mini-review, we emphasize the role of ERα in the brain and liver, summarizing recent evidence that indicates these two organs systems mediate the beneficial effects of estrogens on metabolism and inflammation during aging. We also discuss how 17α-estradiol administration elicits health benefits in an ERα-dependent manner, which provides proof-of-concept that ERα may be a druggable target for attenuating aging and age-related disease burden.</p>\",\"PeriodicalId\":72094,\"journal\":{\"name\":\"Advances in geriatric medicine and research\",\"volume\":\"5 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327608/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in geriatric medicine and research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20900/agmr20230005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in geriatric medicine and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20900/agmr20230005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

雌激素受体α (ERα)在两性生殖功能中起着至关重要的作用。它还介导多种非生殖器官系统对雌激素的细胞反应,其中许多调节哺乳动物的全身代谢稳态和炎症过程。在衰老过程中,雌激素和/或ERα激动作用的丧失与几种合并症的出现有关,特别是在更年期过渡的女性中。新出现的数据还表明,雄性哺乳动物可能受益于ERα激动作用,如果以一种绕过雌性化特征的方式进行的话。这使我们和其他人推测,组织特异性ERα激动作用可能具有治疗潜力,可以减少癌症和/或心血管事件高风险的男性和女性的衰老和慢性疾病负担,传统的雌激素替代疗法。在这篇综述中,我们强调了ERα在大脑和肝脏中的作用,总结了最近的证据表明,这两个器官系统介导了雌激素对衰老过程中代谢和炎症的有益作用。我们还讨论了17α-雌二醇如何以ERα依赖的方式引起健康益处,这提供了ERα可能是减轻衰老和年龄相关疾病负担的可药物靶点的概念证明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Role of Estrogen Receptor α in Aging and Chronic Disease.

Role of Estrogen Receptor α in Aging and Chronic Disease.

Role of Estrogen Receptor α in Aging and Chronic Disease.

Role of Estrogen Receptor α in Aging and Chronic Disease.

Estrogen receptor alpha (ERα) plays a crucial role in reproductive function in both sexes. It also mediates cellular responses to estrogens in multiple nonreproductive organ systems, many of which regulate systemic metabolic homeostasis and inflammatory processes in mammals. The loss of estrogens and/or ERα agonism during aging is associated with the emergence of several comorbid conditions, particularly in females undergoing the menopausal transition. Emerging data also suggests that male mammals likely benefit from ERα agonism if done in a way that circumvents feminizing characteristics. This has led us, and others, to speculate that tissue-specific ERα agonism may hold therapeutic potential for curtailing aging and chronic disease burden in males and females that are at high-risk of cancer and/or cardiovascular events with traditional estrogen replacement therapies. In this mini-review, we emphasize the role of ERα in the brain and liver, summarizing recent evidence that indicates these two organs systems mediate the beneficial effects of estrogens on metabolism and inflammation during aging. We also discuss how 17α-estradiol administration elicits health benefits in an ERα-dependent manner, which provides proof-of-concept that ERα may be a druggable target for attenuating aging and age-related disease burden.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信